Figure 2.

(a) Effect of induced demethylation on the expression levels of RASSF1 transcripts after in vitro treatment with the DNMT inhibitor 5-Aza-2-deoxycytidine (5-Aza-dC) in MECs and BCCs. These data show the average of two independent experiments and technical triplicates for each cell line. (b) Abundance of the RASSF1A and ANRASSF1 transcripts after 5-Aza-dC treatment in each cell line relative to the respective paired untreated control (p-value was determined by the Wilcoxon matched-pairs signed rank test).